175 related articles for article (PubMed ID: 32749816)
1. [Azithromycin to prevent asthma exacerbations: only for patients with non-eosinophilic asthma].
Braunstahl GJ
Ned Tijdschr Geneeskd; 2020 May; 164():. PubMed ID: 32749816
[TBL] [Abstract][Full Text] [Related]
2. [Long-term macrolide therapy in asthma].
Paçacı Çetin G; Arslan B; Yılmaz İ
Tuberk Toraks; 2021 Dec; 69(4):520-534. PubMed ID: 34957746
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Azithromycin Reduces
Taylor SL; Leong LEX; Mobegi FM; Choo JM; Wesselingh S; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Baraket M; Marks GB; Gibson PG; Rogers GB; Simpson JL
Am J Respir Crit Care Med; 2019 Aug; 200(3):309-317. PubMed ID: 30875247
[No Abstract] [Full Text] [Related]
5. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin.
Djamin RS; Talman S; Schrauwen EJA; von Wintersdorff CJH; Wolffs PF; Savelkoul PHM; Uzun S; Kerstens R; van der Eerden MM; Kluytmans JAJW
Antimicrob Resist Infect Control; 2020 Jul; 9(1):116. PubMed ID: 32723393
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
8. Macrolides and airway inflammation in children.
Shinkai M; Rubin BK
Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
[TBL] [Abstract][Full Text] [Related]
9. Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations.
Djamin RS; Bafadhel M; Uzun S; Russell REK; Ermens AAM; Kerstens R; Aerts JGJV; Pavord ID; van der Eerden MM
Respir Med; 2019; 154():27-33. PubMed ID: 31203097
[TBL] [Abstract][Full Text] [Related]
10. Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis.
Hiles SA; McDonald VM; Guilhermino M; Brusselle GG; Gibson PG
Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31515407
[TBL] [Abstract][Full Text] [Related]
11. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Simoens S; Laekeman G; Decramer M
Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
[TBL] [Abstract][Full Text] [Related]
12. Prospects for macrolide therapy of asthma and COPD.
Parnham MJ; Norris V; Kricker JA; Gudjonsson T; Page CP
Adv Pharmacol; 2023; 98():83-110. PubMed ID: 37524493
[TBL] [Abstract][Full Text] [Related]
13. Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease.
Mammen MJ; Sethi S
Pol Arch Med Wewn; 2012; 122(1-2):54-9. PubMed ID: 22353707
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.
Wang D; Fu W; Dai J
Medicine (Baltimore); 2019 Apr; 98(17):e15285. PubMed ID: 31027086
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for macrolides in severe asthma?
Brusselle GG; Joos G
Curr Opin Pulm Med; 2014 Jan; 20(1):95-102. PubMed ID: 24247040
[TBL] [Abstract][Full Text] [Related]
17. Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet?
Restrepo MI; Anzueto A
Am J Respir Crit Care Med; 2014 Jul; 190(1):1-2. PubMed ID: 24983214
[No Abstract] [Full Text] [Related]
18. Macrolide antibiotics for cystic fibrosis.
Southern KW; Barker PM; Solis-Moya A; Patel L
Cochrane Database Syst Rev; 2011 Dec; (12):CD002203. PubMed ID: 22161368
[TBL] [Abstract][Full Text] [Related]
19. Antibiotics for the treatment of asthma.
Black PN
Curr Opin Pharmacol; 2007 Jun; 7(3):266-71. PubMed ID: 17433889
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
